Home › Journal › No. 2131 › Class 99 › Priority claimed from 14/04/2022; Application No. : 4861664 ;France

Priority claimed from 14/04/2022; Application No. : 4861664 ;France · application 5750427, class 99

Advertised in Trade Marks Journal No. 2131 on 20 November 2023. Opposition window closes 20 March 2024.

Priority claimed from 14/04/2022; Application No. : 4861664 ;France

Application
5750427 · filed 16 September 2022
Class
Class 99:
Applicant
[International Registration No. : 1704249] (Applicant, foreign)
Use claimed
Proposed to be used
Advertised
Trade Marks Journal No. 2131, 20 November 2023

Is Priority claimed from 14/04/2022; Application No. : 4861664 ;France trademarked? Every application under this name →

Goods or services claimed

IR DIVISION Cl.5;Injectable pharmaceuticals for treatment of anaphylactic reactions; diagnostic reagents for medical use; reagents for use in medical genetic testing; medical diagnostic products for bacteriological cultures; vaccines; chemical preparations for pharmaceutical use; chemical preparations for medical use; diagnostic preparations for medical use; diagnostic kits for medical diagnostic purposes consisting of reagents for use in disease testing, health monitoring and, more specifically, predictive and preventive medicine in the fields of immune system and respiratory system detection, related diseases, cancer, infectious diseases, inflammatory disorders and oncological disorders; purified biochemicals, namely, protein arrays, fluorescent enzymes and dyes for use as reagents for medical diagnostics; chemical- pharmaceutical preparations; chemical reagents for medical or veterinary use; bacteriological preparations for medical or veterinary use; antiallergic tablets; antibiotics in the form of tablets; traditional Chinese medicinal herbs; biochemical preparations for medical use; bacteriological preparations for pharmaceutical use for the treatment of disorders of the nervous system, immune system, cardiovascular system, metabolic system, respiratory system, musculoskeletal system, genitourinary system, inflammatory disorders, dermatology, oncology, hematology, tissue and organ transplant, ophthalmology and gastroenterological disorders; biochemical medicines for the

Opposition window closes 20 March 2024. This mark has passed examination and is advertised so that anyone with an earlier right can object. A notice of opposition (Form TM-O) may be filed until that date; after it, the application proceeds to registration and the mark can only be challenged by rectification. Whether an opposition is worth filing depends on how close the marks are and whether the goods overlap: see how opposition works.

Similar marks in class 99, same issue

Found by the same matcher that powers Brand Watch: identical, contained, near-spellings and sounds-alike names.

What "advertised" means for Priority claimed from 14/04/2022; Application No. : 4861664 ;France

Advertised is not registered. The Registry examined the application, found no bar (or the applicant overcame the objection), and published it. Registration follows only if no opposition is filed within four months, or if an opposition fails. Until the certificate issues, the applicant may use ™ but not ®. Our guide to trademark status meanings explains each stage, and how long registration takes gives realistic timelines.

Source and corrections. Details are reproduced as advertised by the Registrar of Trade Marks in the Trade Marks Journal (a public record) and may contain errors of transcription. Applicants may ask for a correction or removal of their entry by writing to mehak@trademarkindia.pro. This page is information, not legal advice and not a solicitation.

WhatsApp us